Raul Rodriguez
Chief Executive Officer at RIGEL PHARMACEUTICALS, INC.
Net worth: 2 M $ as of 2024-04-29
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Gregg Lapointe | M | 65 | 7 years | |
Gary Lyons | M | 73 | 19 years | |
Walter Moos | M | 69 | 27 years | |
Jane Wasman | F | 67 | 5 years | |
Kamil Ali-Jackson | F | 65 | 3 years | |
Raymond Furey | M | 56 | 2 years | |
Alison Hannah | M | 63 | 3 years | |
Brian Kotzin | M | 74 | 7 years | |
Dean Schorno | M | 61 | 6 years | |
Joseph Lasaga | M | - | 26 years | |
Esteban S. Masuda | M | - | 8 years | |
Julie Patel | F | - | 2 years | |
David Santos | M | 61 | 4 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Donald G. Payan | M | 75 | 20 years | |
Dolly Vance | F | 59 | 22 years | |
James M. Gower | M | 75 | 18 years | |
Roberto Pedro Rosenkranz | M | 74 |
Scios, Inc.
Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | 1 years |
Bradford Goodwin | M | 69 | - | |
Hollings Renton | M | 77 | 10 years | |
Stephen Sherwin | M | 75 | 17 years | |
Daniel B. Magilavy | M | - | - | |
Bruce A. Leicher | M | 68 |
Ontogeny, Inc.
Ontogeny, Inc. BiotechnologyHealth Technology Ontogeny, Inc., located in Cambridge, Massachusetts whose mission is to become the preeminent biopharmaceutical company focused on translating developmental biology insights into regenerative medicine therapies that will significantly improve the quality of life by activating the body's ability to repair and regenerate, or to specifically control abnormal and malignant growth. The Company is developing therapeutics for neurological diseases including Parkinson's and Alzheimer's diseases, diabetes and dermatological disorders including skin cancer and hair growth. | - |
David Burke | M | - | 3 years | |
James Welch | M | 66 | 7 years | |
Nelson Cabatuan | M | 47 | 12 years | |
Peter S. Ringrose | M | 78 | 14 years | |
Keith Katkin | M | 52 | 7 years | |
Ryan Maynard | M | 54 | 16 years | |
Jodi A. Sievers | F | - | 1 years | |
Michael Crockett | M | - |
Scios, Inc.
Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | - |
Lily Cheung | F | 51 | 3 years | |
Donald B. Rice | M | 83 |
Scios, Inc.
Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | 6 years |
Francesco Parlati | M | 55 | 2 years | |
Wolfgang Dummer | M | 58 | 4 years | |
Stacy Markel | F | 59 | 1 years | |
Rajinder Singh | M | - | 18 years | |
Giovanna Matthews | F | - | 3 years | |
Dana Pizzuti | M | 69 | 2 years | |
Eldon Mayer | M | 62 | 3 years | |
Arlene Morris | F | 72 |
Scios, Inc.
Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | 3 years |
Anne-Marie S. Duliege | M | 64 | 3 years | |
Garry Nolan | M | 63 | 6 years | |
Mark K. Bennett | M | 65 | 4 years | |
Susan Molineaux | M | 70 | 3 years | |
George F. Schreiner | M | 74 |
Scios, Inc.
Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | 9 years |
Alan Frazier | M | 72 | 9 years | |
Elliott B. Grossbard | M | 76 | 14 years | |
Lee L. Rubin | M | 73 |
Ontogeny, Inc.
Ontogeny, Inc. BiotechnologyHealth Technology Ontogeny, Inc., located in Cambridge, Massachusetts whose mission is to become the preeminent biopharmaceutical company focused on translating developmental biology insights into regenerative medicine therapies that will significantly improve the quality of life by activating the body's ability to repair and regenerate, or to specifically control abnormal and malignant growth. The Company is developing therapeutics for neurological diseases including Parkinson's and Alzheimer's diseases, diabetes and dermatological disorders including skin cancer and hair growth. | 3 years |
Jean Deleage | M | 83 | 14 years | |
Nicholas Simon | M | 67 | - | |
Dennis J. Henner | M | 72 | - | |
Robin D. G. Cooper | M | 85 | - | |
Garry Nolan | M | - | 6 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 53 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Raul Rodriguez
- Personal Network